-
Expression of CXCR4 in the Primary Lesion of Recurrent Metastatic Breast Cancer and Its Association With Prognosis
18 Mar 2025 09:41 GMT
… of recurrent metastatic breast cancer patients, analyzing its … Primary Lesion and Breast Cancer Clinical Characteristics. Statistics … acquired resistance to gefitinib in lung adenocarcinoma … into molecular mechanisms of breast cancer metastasis. NPJ Precision …
-
Advances in Ultrasound-Targeted Microbubble Destruction (UTMD) for Breast Cancer Therapy
03 Feb 2025 12:15 GMT
… cases of highly malignant breast cancers, including TNBC, … Breast Cancer Therapy
UTMD in the Chemotherapy of Breast Cancer
Breast cancer … of orally administered gefitinib in mice with … therapy treatment of breast tumours using ultrasound responsive …
-
Ginger-Derived Exosome-Like Nanoparticles Loaded With Indocyanine Green Enhances Phototherapy Efficacy for Breast Cancer
30 Jan 2025 07:20 GMT
… mediated breast tumor therapy effect by directly inhibiting breast tumor … significantly facilitated photo-mediated breast tumor therapy. Furthermore, the … 6-Shogaol Overcomes Gefitinib Resistance via ER Stress … with basal-like breast cancer cell invasion. J …
-
Improving the Cytotoxic Activity of Hinokitiol from Drug-Loaded Phytosomal Formulation Against Breast Cancer Cell Lines
12 Oct 2024 09:01 GMT
… effective agents against breast cancer. The results demonstrated … effective agents for breast cancer treatment, warranting further … effective and targeted breast cancer therapeutics. Molecular docking … and senescence in gefitinib-resistant lung adenocarcinoma …
-
Combinatorial CRISPR screen reveals FYN and KDM4 as targets for synergistic drug combination for treating triple negative breast cancer
29 Feb 2024 19:49 GMT
… microarray data of primary breast cancers of GSE25066 cohort, and … upregulation in triple-negative breast cancer (TNBC) compared to … NVP-ADW742 treatment, gefitinib treatment increased KDM4 demethylase … various cancers, including breast cancer, and promotes key …
-
Research Progress of GPR137 in Malignant Tumors: A Review
14 Apr 2025 14:59 GMT
… ) with erlotinib and gefitinib has greatly enhanced the … cancers such as cholangiocarcinoma, breast cancer, prostate cancer, ovarian … HER2 for metastatic breast cancer that overexpresses HER2. … of chemokine receptors in breast cancer metastasis. Nature. 2001; …
-
Cost-Effectiveness Analysis of Serplulimab Combined with Nab-Paclitaxel Plus Carboplatin Compared to Nab-Paclitaxel Plus Carboplatin Alone as First-Line Treatment for Advanced Squamous Non-Small Cell Lung Cancer in China
14 Apr 2025 14:59 GMT
… , Wu B. Cost-effectiveness of gefitinib, icotinib, and pemetrexed-based chemotherapy … -line therapy for HER2-positive breast cancer in China. Clin. Drug Invest …
-
Molecular Biology Mechanisms and Emerging Therapeutics of Triple-Negative Breast Cancer
20 Sep 2023 16:40 GMT
… approach to characterizing breast tumors.26 Based on … portraits of human breast tumours. Nature. 2012;490 … medullary breast cancer is a subgroup of basal breast cancers. … gefitinib in taxane- and anthracycline-pretreated metastatic breast cancer. Breast Cancer …
-
Research Progress on Molecular Subtyping and Modern Treatment of Triple-Negative Breast Cancer
24 Aug 2023 08:11 GMT
… stage breast cancer patients, patients were given either gefitinib … of triple negative breast cancers expressing CTLA-4. … -negative breast tumor growth by targeting GD2 + breast cancer stem … in triple-negative breast cancer. Breast Cancer Res Treat. 2022 …
-
Integrated Genomic Analysis of Lung Squamous Cell Carcinoma Subtypes Characterized by Immunogenic Cell Death-Relevant Gene Signature
10 Apr 2025 22:33 GMT
… sensitivity data for Sorafenib, Gefitinib, Bleomycin, Bosutinib, Etoposide, … for (a) Sorafenib, (b) Gefitinib, (c) Bleomycin, (d) … signatures in triple-negative breast cancer. Front Oncol. … al. Identification of breast cancer subtypes by integrating genomic …
About
© 1995-2025